EU agency recommends extended approval of Roche's Actemra

04/26/2010 | Reuters

Roche Holding said the European Medicines Agency recommended extended approval of Actemra, an anti-interleukin-6 receptor antibody, for use in combination with standard treatment methotrexate in patients with rheumatoid arthritis. The company received the recommendation after providing the EU agency with two years of clinical data.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ